RPRodrigo C. Paiva

Rodrigo C. Paiva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rodrigo C. Paiva has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A multivalent mRNA-lipid nanoparticle vaccine containing eight hemagglutinin antigens elicited broad neutralizing antibody responses and protected against influenza A virus challenge in swine

    by Giovana Ciacci Zanella, Marissa L. Vincent, Leo Flores, Ethan K. Aljets, Rodrigo C. Paiva, Alexey Markin, Blake Inderski, Garima Dwivedi, Drew Weissman, Meghan Wymore Brand, et al.

    The diversity within H1 and H3 subtype influenza A viruses (IAVs) in swine prevents effective vaccine control approaches with inactivated whole-virus vaccines. We addressed the challenge of controlling co-circulating hemagglutinin (HA) clades of swine IAV with the development of a multivalent messenger RNA (mRNA)–lipid nanoparticle (LNP) vaccine expressing eight HA proteins to maximize genetic coverage. We applied a computational approach to select eight HA genes that represented 95% of the observed IAVs detected in the United States between 2022 and 2025. Piglets were vaccinated and boosted intramuscularly with either individual HA mRNA–LNP or an 8-HA multivalent mRNA–LNP. Serum was collected to evaluate systemic antibody levels. Twenty-one days post-boost, pigs were challenged with a field-relevant H1 1A.3.3.3-c3 IAV strain. The 8-HA multivalent mRNA–LNP vaccine induced neutralizing antibodies against all eight antigens, and vaccinees were protected against lung lesions, with lesion scores similar to non-challenged animals. Homologous monovalent vaccination significantly reduced IAV detection in nasal secretions and in the lungs. Heterologous monovalent vaccination was not cross-protective but did not induce vaccine-associated enhanced respiratory disease. We provide evidence that monovalent and multivalent mRNA–LNP influenza vaccines elicited neutralizing antibody responses in pigs and protected against viral challenge. The versatility and capacity for rapidly updating the mRNA–LNP vaccine platform make it an appealing tool to improve animal health and minimize the circulation and diversity of IAV in swine. IMPORTANCE: Influenza A virus (IAV) is an important respiratory pathogen in swine, and zoonotic transmission of swine strains to humans remains a public health risk. Control strategies against IAV in swine herds rely heavily on biosecurity measures and vaccination. However, the antigenic diversity of IAV circulating in swine challenges current vaccination programs, and there is a need for broadly protective vaccines or platforms that can rapidly update components to reflect circulating diversity. mRNA–LNP vaccines have emerged as promising vaccine platforms, offering simultaneous delivery of multiple antigens, rapid development, scalable manufacturing, and potent immunogenicity. In this study, we assessed the immunogenicity and protective capacity of monovalent and multivalent mRNA–LNP vaccines encoding eight representative IAV hemagglutinin (HA) antigens. To our knowledge, this is the first study to objectively select multiple representative endemic swine IAV strains by quantifying genetic diversity within the phylogeny and to apply this selection to rationally design and evaluate a multivalent HA mRNA-based influenza vaccine in the swine model.

  • Open Access

    A multivalent mRNA-lipid nanoparticle vaccine containing eight hemagglutinin antigens elicited broad neutralizing antibody responses and protected against influenza A virus challenge in swine.

    by Giovana Ciacci Zanella, Marissa L. Vincent, Leo Flores, Ethan K. Aljets, Rodrigo C. Paiva, Alexey Markin, Blake T Inderski, Garima Dwivedi, Drew Weissmann, Meghan Wymore Brand, et al.

    The diversity within H1 and H3 subtype influenza A viruses (IAV) in swine prevents effective vaccine control approaches with inactivated whole-virus vaccines. We addressed the challenge of controlling co-circulating hemagglutinin (HA) clades of swine IAV with the development of a multivalent mRNA-lipid nanoparticle (LNP) vaccine expressing 8 HA proteins to maximize genetic coverage. We applied a computational approach to select eight HA genes that represented 95% of the observed IAV detected in the United States between 2022 and 2025. Piglets were vaccinated and boosted intramuscularly with either individual HA mRNA-LNP or an 8-HA multivalent mRNA-LNP. Serum was collected to evaluate systemic antibody levels. Twenty-one days post-boost, pigs were challenged with a field relevant H1 1A.3.3.3-c3 IAV strain. The 8-HA multivalent mRNA-LNP vaccine induced neutralizing antibodies against all eight antigens and vaccinees were protected against lung lesions, with lesion scores similar to non-challenged animals. Homologous monovalent vaccination significantly reduced IAV detection in nasal secretions and in the lungs. Heterologous monovalent vaccination was not cross-protective but did not induce vaccine-associated enhanced respiratory disease. We provide evidence that monovalent and multivalent mRNA-LNP influenza vaccines elicited neutralizing antibody responses in pigs and protected against viral challenge. The versatility and capacity for rapidly updating the mRNA-LNP vaccine platform make it an appealing tool to improve animal health and minimize the circulation and diversity of IAV in swine.

  • Systemic toxoplasmosis in weaned pigs in Pennsylvania, USA, with a brief review of the literature

    by Rodrigo C. Paiva, Eric R. Burrough, Christopher L. Siepker, Mike Pierdon, Anthony Holowka, Darin M. Madson

    Toxoplasma gondii is an important apicomplexan parasite in veterinary medicine, with swine prevalence varying due to age, geographic distribution, and production program. Samples from a 6-wk-old pig from a small backyard farm with multisystemic disease concerns were submitted to the Iowa State University–Veterinary Diagnostic Laboratory. Gross findings included severe necrotizing enteritis with pseudomembrane formation and edematous, non-collapsing lungs. Histologic findings were severe necrotizing enterocolitis and random multifocal pulmonary and hepatic necrosis with numerous intralesional protozoal cysts consistent with T. gondii . Immunohistochemistry, reverse-transcription real-time PCR (RT-rtPCR), and serologic tests were positive for T. gondii ; concurrent influenza A virus, porcine reproductive and respiratory syndrome virus, porcine circovirus 2, African swine fever virus, and classical swine fever virus were ruled out by RT-rtPCR. Given the worldwide distribution and zoonotic potential of T. gondii , the possibility of infection in swine should be considered.


  • Open Access

    Description of a contemporary pathogenic Escherichia coli isolated from pigs with post-weaning diarrhea in the United States from 2010 to 2023

    by Rodrigo C. Paiva, Eric R. Burrough, Nubia Macedo, Ana Paula S. P. Silva, Maud de Lagarde, John M. Fairbrother, Pablo E. Piñeiro, Marcelo N. Almeida

    Post-weaning diarrhea (PWD) due to Escherichia coli in pigs is a significant enteric disease in the U.S. Contemporary data about the main virulence factors, colony morphology, and distribution of virotypes of isolates associated with post-weaning colibacillosis (PWC) is essential information for swine veterinarians, producers, and stakeholders. This study reports the rate of PWC/PWD, frequency of detection of fimbrial types, pathotypes, toxins, virotypes, morphological characteristics, and temporal analysis of the most prevalent virotype of enterotoxigenic E. coli recovered from cases of PWD in pigs in the United States. There was a significant increase in PWC cases submitted to the diagnostic laboratory in 2013, 2014, and 2021, respectively. A greater frequency of detection of F18 fimbrial adhesin (69.87%) was observed compared to F4 (26.19%), F5 (0.25%), F41 (0.13%), AIDA (0.10%), and multiple adhesins (3.46%), respectively. Hybrid ETEC:STEC pathotype was greater than ETEC and STEC, and STb toxin was present in 93.33% of the detected isolates. The most frequently observed virotype was F18:LT:STa:STb:Stx2e (27.71%). Smooth:mucoid colony morphology was associated with a greater likelihood of PWC (0.758, 0.968, and 0.993) compared to smooth, intermediate, and rough, respectively. The frequency of the F18:LT:STa:STb:Stx2e virotype increased across all U.S. states from 2016 to 2023, greatest in the northwest and east of Iowa and northeast Indiana in 2022 and Iowa in 2023. The virulence factors and morphology of enterotoxigenic E. coli associated with PWC across different states in the U.S. from 2010 to 2023 were diverse; nevertheless, the virotype F18:LT:STa:STb:Stx2e predominated and increased in frequency during this time period.